Skip to content

To compare the efficacy of two fascial plane block technique for Breast cancer surgery

A comparative evaluation of analgesic efficacy of Serratus anterior with Erector spinae fascial plane block along with General Anaesthesia for Breast cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/10/037221
Enrollment
100
Registered
2021-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site Health Condition 2: O- Medical and Surgical Health Condition 3: O- Medical and Surgical

Interventions

Intervention1: Erector spinae fascial plane block: USG guided Erector spinae fascial plane block will be given using 0.4ml/kg Ropivacaine 0.25% + 1mcg/kg Fentanyl (max 30ml). Patient will be monitored

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 All female non pregnant patients 18-65 years of age with no comorbidities 2 ASA class I-II 3 BMI 4 Having unilateral breast cancer that may or may not involve the axilla

Exclusion criteria

Exclusion criteria: 1 ASA class lll-Vl 2 BMI >35kg/m2 3 Patient refusal 4 Allergy to ropivacaine or fentanyl 5 Patients undergoing breast reconstruction surgery 6 Prior ipsilateral breast surgery, excluding lumpectomy 7 Pre-existing neurological deficit or peripheral neuropathy involving the ipsilateral chest 8 Severe, poorly controlled cardiac and respiratory conditions like arrhythmias, valvular heart diseases, COPD, Interstitial lung disease, poorly controlled asthma 9 Contraindication to regional or general anaesthesia (e.g. bleeding diathesis, coagulopathy, sepsis, infection at the site of potential needle puncture) 10 Pre-existing chronic pain disorder 11 Significant psychiatric disorder that would preclude objective study assessment 11 Pregnancy 12 Unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
Post op pain scores [Time frame: 24 hours post op] Patients level of post op pain will be evaluated using visual analogue scale (VAS). Range between 0- 10.Timepoint: Post op pain scores [Time frame: 24 hours post op] Patients level of post op pain will be evaluated using visual analogue scale (VAS). Range between 0- 10.

Secondary

MeasureTime frame
1Sensory block onset assessment- pinprick sensation test [Time frame- End of surgical procedure until 24 hours post op] 2 Mean analgesic consumption [Time frame- 24 hours post op] Cumulative I/V Tramadol or PCM 1gm equivalent after surgery 3 Time to first analgesic request [Time frame- 24 hours post op] The time when patient requires first analgesic post op 4 Block related complications [Time frame- End of surgical procedure to 1 month post op] Presence/absence of block related side effects such as bruising, infection, systemic toxicity, persistent numbness Timepoint: 1 Sensory block onset assessment- pinprick sensation test [Time frame- End of surgical procedure until 24 hours post op] 2 Mean analgesic consumption [Time frame- 24 hours post op] 3 Time to first analgesic request [Time frame- 24 hours post op] 4 Block related complications [Time frame- Post op to 1 month] Evaluation to be done @ 24 hours, 7 days and 1 month

Countries

India

Contacts

Public ContactDr Nimisha Verma

Institute of Medical sciences Sir Sundarlal Hospital Banaras Hindu University

verma.nimisha5@gmail.com9559955988

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026